Investors irked by lack of disclosures at Sun Pharma

The lack of disclosures around non-related party transactions to the tune of Rs 2,200 crore has become a sore spot for investors, who are questioning the nature — and beneficiaries — of these loans.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2KToVCs
via IFTTT